Aurora Medicine UK

Aurora Cannabis Bounces Back: Debt Paid, Growth Ahead
Aurora Cannabis has repaid its convertible senior notes, marking a significant milestone as it nears financial recovery. With remaining debt related to Bevo Farms Ltd, CEO Miguel Martin highlighted the company's focus on balance sheet strength, having paid off a substantial amount in convertible debt. The company posted record earnings in the third quarter, attributing success to international expansion and strategic partnerships, such as the recent collaboration with Script Assist in the UK. Analysts have identified Aurora as well-positioned to benefit from the legalization wave in Germany, given its strong export ties to the country. With a focus on medical cannabis quality and patient care, Aurora aims for positive free cash flow by year-end, showcasing a commitment to financial discipline and growth in the global cannabis market.
UK Medical Cannabis Market Gets Boost With Aurora And Script Assist Collaboration
Aurora Cannabis has partnered with Script Assist, a UK medical cannabis prescription platform. The collaboration will offer a range of Aurora's medical cannabis products in the UK, including three new cannabis flower products launching in March. These products aim to provide UK patients with high-quality options, such as those with high THC content or balanced THC/CBD ratios. The partnership will also introduce 'Find a Doctor' on the platform to connect patients with specialized prescribing doctors. Trisha Cassidy, a managing director at Aurora UK and Ireland, highlighted the importance of improving access to medical cannabis products and providing valuable information to support patients. Overall, the partnership between Aurora and Script Assist aims to enhance the UK medical cannabis landscape and assist patients on their medical cannabis journey.